Home » 15: Real-World evidence shows no survival advantage with contemporary first-line strategies in papillary renal cell carcinoma: a call for randomized trials – PMC
15: Real-World evidence shows no survival advantage with contemporary first-line strategies in papillary renal cell carcinoma: a call for randomized trials – PMC
by Miguel Zugman, Jennifer R Rider, Nazli Dizman, Salvador Jaime-Casas, Vitor Abreu Goes, Koral Shah, Daniela V Castro, Benjamin Mercier, Peter Zang, Hedyeh Ebrahimi, Regina Barragan-Carrillo, Diwyanshu Sahu, Prithviraj Vikramsinh Mandora, JoAnn Hsu, Wesley Yip, Charles B Nguyen, Alex Chehrazi-Raffle, Robert Miller, Thomas Powles, Toni Choueiri & Sumanta K Pal | Oct 10, 2025 | Articles |
